Bernard Coulie
President and CEO at Pliant Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Pliant Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 23, 2025 | Pliant Therapeutics Inc. | Grant or award | +162,500 | โ | โ |
| Jan 17, 2025 | Pliant Therapeutics Inc. | Open-market sale | โ52,419 | $11.20 | $587,093 |
| Jul 10, 2024 | Pliant Therapeutics Inc. | Open-market sale | โ38,710 | $11.56 | $447,488 |
| Jul 9, 2024 | Pliant Therapeutics Inc. | Grant or award | +75,625 | โ | โ |
| Jan 23, 2024 | Pliant Therapeutics Inc. | Grant or award | +128,150 | โ | โ |
| Jan 17, 2024 | Pliant Therapeutics Inc. | Open-market sale | โ25,721 | $17.23 | $443,173 |
| Jul 17, 2023 | Pliant Therapeutics Inc. | Open-market sale | โ70,150 | $18.01 | $1,263,402 |
| Jul 14, 2023 | Pliant Therapeutics Inc. | Grant or award | +137,500 | โ | โ |
| Mar 30, 2023 | Pliant Therapeutics Inc. | Open-market sale | โ35,339 | $26.52 | $937,190 |
| Mar 29, 2023 | Pliant Therapeutics Inc. | Grant or award | +68,749 | โ | โ |
| Feb 3, 2023 | Pliant Therapeutics Inc. | Option exercise | +15,000 | $6.22 | $93,300 |
| Feb 3, 2023 | Pliant Therapeutics Inc. | Open-market sale | โ9,738 | $33.36 | $324,860 |
| Feb 3, 2023 | Pliant Therapeutics Inc. | Open-market sale | โ5,262 | $34.08 | $179,329 |
| Feb 2, 2023 | Pliant Therapeutics Inc. | Option exercise | +15,000 | $6.22 | $93,300 |
| Feb 2, 2023 | Pliant Therapeutics Inc. | Open-market sale | โ13,395 | $34.13 | $457,171 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.